Journey Medical Corp Payments of Stock Issuance Costs
Journey Medical Corp (DERM) reported Payments of Stock Issuance Costs of $371.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2023-11-13
- Journey Medical Corp payments of stock issuance costs for the quarter ending 2022-12-31 was $0.00.
- Journey Medical Corp payments of stock issuance costs for the quarter ending 2022-09-30 was $0.00.
- Journey Medical Corp payments of stock issuance costs for the quarter ending 2022-06-30 was $0.00.
- Journey Medical Corp payments of stock issuance costs for the quarter ending 2022-03-31 was $371.00K.
- Journey Medical Corp payments of stock issuance costs for fiscal 2022 was $371.00K, a 76.06% decline from fiscal 2021.
- Journey Medical Corp payments of stock issuance costs for fiscal 2021 was $1.55M.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $0.00 derived: sum of 2 quarters · filed 2023-11-13 | $0.00 derived: sum of 3 quarters · filed 2023-11-13 | $371.00K 10-K · filed 2023-03-31 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $0.00 derived: sum of 2 quarters · filed 2023-11-13 | $371.00K 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $371.00K 10-Q · filed 2023-08-10 | ||
| 2022-03-31 | $371.00K 10-Q · filed 2023-05-22 | |||
| 2021-12-31 | $1.55M 10-K · filed 2023-03-31 |